Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$41.99 - $62.38 $143,353 - $212,965
3,414 New
3,414 $200,000
Q1 2022

May 13, 2022

SELL
$75.82 - $150.97 $201,302 - $400,825
-2,655 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$132.01 - $190.29 $350,486 - $505,219
2,655 New
2,655 $389,000
Q2 2021

Aug 12, 2021

SELL
$144.0 - $179.73 $453,600 - $566,149
-3,150 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$158.92 - $221.61 $500,597 - $698,071
3,150 New
3,150 $540,000

Others Institutions Holding MRTX

About Mirati Therapeutics, Inc.


  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.